Ligand source activities (1 row/activity)





Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type

Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI

1599 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
3955 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
3955.0 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
7215 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
CHEMBL841 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
DB00836 2341 None 28 Human Functional pEC50 = 5.7 5.7 -1096 32
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 476 7 1 3 5.1 Clc1ccc(cc1)C1(O)CCN(CC1)CCC(C(=O)N(C)C)(c1ccccc1)c1ccccc1 10.6019/CHEMBL5442687
11316919 3068 None 31 Human Functional pEC50 = 5.7 5.7 -3 8
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
11693 3068 None 31 Human Functional pEC50 = 5.7 5.7 -3 8
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
CHEMBL484929 3068 None 31 Human Functional pEC50 = 5.7 5.7 -3 8
GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in agonist mode with target: ADGRF1
ChEMBL 451 4 0 4 5.3 Clc1c(cccc1)n1nc2C(=O)N(CCOc2c1c1ccc(cc1)Cl)CC(C)(F)F 10.6019/CHEMBL5442687
5311122 4068 None 4 Human Functional pIC50 = 5.7 5.7 -173 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 456 7 0 3 6.5 COc1ccc2c(c1)C(CCC2)C(=O)N(c1ccc(cc1)C(C)C)Cc1ccc(cc1)N(C)C 10.6019/CHEMBL5442687
581 4068 None 4 Human Functional pIC50 = 5.7 5.7 -173 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 456 7 0 3 6.5 COc1ccc2c(c1)C(CCC2)C(=O)N(c1ccc(cc1)C(C)C)Cc1ccc(cc1)N(C)C 10.6019/CHEMBL5442687
CHEMBL1628668 4068 None 4 Human Functional pIC50 = 5.7 5.7 -173 4
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 456 7 0 3 6.5 COc1ccc2c(c1)C(CCC2)C(=O)N(c1ccc(cc1)C(C)C)Cc1ccc(cc1)N(C)C 10.6019/CHEMBL5442687
6603703 208 None 8 Human Functional pIC50 = 5.6 5.6 -870 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
9637 208 None 8 Human Functional pIC50 = 5.6 5.6 -870 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
CHEMBL291143 208 None 8 Human Functional pIC50 = 5.6 5.6 -870 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 329 2 3 4 3.3 NC[C@@H]1O[C@@H](Cc2c1ccc(c2O)O)C12CC3CC(C2)CC(C1)C3 10.6019/CHEMBL5442687
1692 2154 None 25 Human Functional pIC50 = 5.6 5.6 -93 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
5311340 2154 None 25 Human Functional pIC50 = 5.6 5.6 -93 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
CHEMBL140979 2154 None 25 Human Functional pIC50 = 5.6 5.6 -93 18
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 411 6 2 4 5.5 CCc1ccc(cc1)OCc1ccccc1C(=O)Nc1ccc2c(c1)c(N)cc(n2)C 10.6019/CHEMBL5442687
42611190 3156 None 14 Human Functional pIC50 = 5.5 5.5 -831 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
5802 3156 None 14 Human Functional pIC50 = 5.5 5.5 -831 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
CHEMBL1800685 3156 None 14 Human Functional pIC50 = 5.5 5.5 -831 21
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 475 4 2 2 7.4 OC(=O)c1cc2cc(ccc2c(c1)c1ccc(cc1)C1CCNCC1)c1ccc(cc1)C(F)(F)F 10.6019/CHEMBL5442687
2419 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
5152 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
5152.0 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
559 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
CHEMBL1263 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
DB00938 3463 None 53 Human Functional pIC50 = 5.5 5.5 -6025 19
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 415 16 4 5 4.1 OCc1cc(ccc1O)C(CNCCCCCCOCCCCc1ccccc1)O 10.6019/CHEMBL5442687
28 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
3292447 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
CHEMBL20963 3496 None 35 Human Functional pIC50 = 5.4 5.4 -1 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 486 9 1 7 5.2 COc1ccc(cc1OCCN(C)C)NC(=O)c1ccc(cc1)c1ccc(cc1C)c1noc(n1)C 10.6019/CHEMBL5442687
10150497 4074 None 40 Human Functional pIC50 = 5.4 5.4 -630 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
3240 4074 None 40 Human Functional pIC50 = 5.4 5.4 -630 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
CHEMBL392760 4074 None 40 Human Functional pIC50 = 5.4 5.4 -630 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 380 4 1 7 2.7 NCCc1cn(c2c1cccc2)S(=O)(=O)c1c(Cl)nc2n1ccs2 10.6019/CHEMBL5442687
44634573 2748 None 1 Human Functional pIC50 = 5.3 5.3 -588 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
9168 2748 None 1 Human Functional pIC50 = 5.3 5.3 -588 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1474387 2748 None 1 Human Functional pIC50 = 5.3 5.3 -588 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
CHEMBL1622930 2748 None 1 Human Functional pIC50 = 5.3 5.3 -588 15
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 465 6 0 2 5.0 Cc1n(C/C=C/c2ccccc2)c2[n+](c1P(=S)(c1ccccc1)c1ccccc1)cccc2 10.6019/CHEMBL5442687
662 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
9853583 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687
CHEMBL2021721 3680 None 7 Human Functional pIC50 = 5.3 5.3 -2 12
GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1GPCR PRESTO-Tango dose-response in antagonist mode with target: ADGRF1
ChEMBL 756 14 2 8 6.3 COc1ccc2c(c1)ccc(c2)S(=O)(=O)N[C@@H](c1ccc2c(c1)OCO2)CC(=O)N[C@@H](C(=O)N(C(C)C)C)Cc1ccc(cc1)CN1[C@H](C)CCC[C@@H]1C 10.6019/CHEMBL5442687




Ligands (move mouse cursor over ligand name to see structure) Receptor Activity Chemical information
Sel. page Common
name
GPCRdb
ID
Reference
ligand
Vendors

Species

Assay
Type
Activity
Type
Activity
Relation
Activity
Value
p-value
(-log)
Fold
selectivity
Tested
GPCRs
Assay
Description
Source

Mol
weight
Rot
Bonds
H don

H acc

LogP

Smiles

DOI